Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes

Oct-16

Cardiovascular Endocrinology Pharmacoepidemiology

AUTHORS : Dr Iskandar Idris, University of Nottingham, Division of Medical Sciences and Graduate Entry Medicine, School of Medicine, Royal Derby Hospital , Uttoxeter Road, Derby DE22 3DT – Email: Iskandar.Idris@nottingham.ac.uk – Profile: https://www.nottingham.ac.uk/medicine/people/iskandar.idris

JOURNAL : Heart

REFERENCE: 102(19):1581-7

DOI : 10.1136/heartjnl-2015-309164

Cardiovascular events and all-cause mortality with insulin versus glucagon-like peptide-1 analogue in type 2 diabetes

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study